A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination with Baxdrostat in Healthy Females of Non-childbearing Potential

Trial Identifier: D6970C00006
Sponsor: AstraZeneca
NCTID:: NCT06657105
Start Date: November 2024
Primary Completion Date: February 2025
Study Completion Date: February 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225